Check out the companies making the biggest pre-market moves: Roivant Sciences — Shares rose 24% after the drug company announced that subsidiary Pulmovant’s Phase 2 trial results for mosliciguat demonstrated a “clinically meaningful and statistically significant placebo-adjusted reduction in pulmonary vascular resistance” in patients with pulmonary hypertension associated with interstitial lung disease. Lockheed Martin — The defense contractor rose 0.7% after UBS upgraded the stock to buy from neutral, saying its revenue growth potential was undervalued. Novartis — The drugmaker fell 12% after Phase 3 results showed the drug deldesiran did not produce “significant improvement” in patients with myotonic dystrophy type 1. Peloton Interactive — Shares fell more than 4% after Morgan Stanley downgraded the stock from equal weight to underweight. “PTON faces structural headwinds in the fitness space,” Morgan Stanley said. Boston Scientific — The medical device maker fell more than 2% after the company said a recent cyberattack could impact its 2026 sales and profit targets. Bloom Energy — The fuel cell maker is up more than 6% as it prepares to join the S&P 500 on Sept. 21. Bloom has benefited greatly from building AI data centers. The company’s stock price is up about 190% this year. Quantum Computing Stocks – The quantum computing sector rallied after the US announced it had agreed to take minority stakes in several companies as part of a $300 million CHIPS Act deal. Investments will be made in D-Wave Quantum, Rigetti Computing, and Quantinuum. D-Wave stock rose more than 5%, Rigetti rose nearly 14% and Quantinuum rose another 4%. —CNBC’s Christina Cheddar Burke contributed to this report.
